A detailed history of Morgan Stanley transactions in Royalty Pharma PLC stock. As of the latest transaction made, Morgan Stanley holds 44,217,885 shares of RPRX stock, worth $1.21 Billion. This represents 0.11% of its overall portfolio holdings.

Number of Shares
44,217,885
Previous 46,354,266 4.61%
Holding current value
$1.21 Billion
Previous $1.3 Billion 3.13%
% of portfolio
0.11%
Previous 0.12%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$27.46 - $31.33 $58.7 Million - $66.9 Million
-2,136,381 Reduced 4.61%
44,217,885 $1.34 Billion
Q4 2023

Feb 13, 2024

SELL
$26.21 - $29.22 $46.6 Million - $52 Million
-1,778,349 Reduced 3.69%
46,354,266 $1.3 Billion
Q3 2023

Nov 15, 2023

BUY
$26.26 - $31.38 $18.5 Million - $22.1 Million
702,754 Added 1.48%
48,132,615 $1.31 Billion
Q2 2023

Aug 14, 2023

BUY
$29.6 - $36.56 $2.35 Million - $2.9 Million
79,403 Added 0.17%
47,429,861 $1.46 Billion
Q1 2023

May 15, 2023

SELL
$32.77 - $39.4 $62.1 Million - $74.7 Million
-1,895,574 Reduced 3.85%
47,350,458 $1.71 Billion
Q4 2022

Feb 14, 2023

SELL
$39.17 - $44.04 $36.8 Million - $41.4 Million
-940,129 Reduced 1.87%
49,246,032 $1.95 Billion
Q3 2022

Nov 14, 2022

SELL
$39.88 - $44.65 $54.1 Million - $60.6 Million
-1,357,010 Reduced 2.63%
50,186,161 $2.02 Billion
Q2 2022

Oct 27, 2022

SELL
$37.53 - $44.22 $75 Million - $88.4 Million
-1,998,617 Reduced 3.73%
51,543,171 $2.17 Billion
Q2 2022

Aug 15, 2022

SELL
$37.53 - $44.22 $75 Million - $88.4 Million
-1,998,617 Reduced 3.73%
51,543,171 $2.17 Billion
Q1 2022

Oct 27, 2022

BUY
$37.46 - $42.44 $74.9 Million - $84.8 Million
1,998,617 Added 3.88%
53,541,788 $2.09 Billion
Q1 2022

May 13, 2022

SELL
$37.46 - $42.44 $101 Million - $114 Million
-2,688,902 Reduced 4.78%
53,541,788 $2.09 Billion
Q4 2021

Feb 14, 2022

SELL
$35.17 - $42.48 $37.8 Million - $45.6 Million
-1,074,621 Reduced 1.88%
56,230,690 $2.24 Billion
Q3 2021

Nov 15, 2021

BUY
$36.14 - $42.24 $2.07 Billion - $2.42 Billion
57,305,311 New
57,305,311 $2.07 Billion

Others Institutions Holding RPRX

About Royalty Pharma plc


  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $12B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.